Roffman Miller Associates’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Roffman Miller Associates's RMD Position: Q3 2023 in Review
Roffman Miller Associates sold out of ResMed (RMD) in Q3 2023, closing a stake of 16 shares — an estimated $3.5K sold.
Roffman Miller Associates first reported a position in RMD in Q2 2013 and held it in 17 quarters. The position peaked at $4.37M in Q1 2015. 657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.
- Roffman Miller Associates reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
- Roffman Miller Associates sold 16 ResMed shares in Q3 2023, an estimated $3.5K.
- Roffman Miller Associates first reported a position in ResMed in Q2 2013 and held it in 17 quarters.
- Roffman Miller Associates's ResMed position peaked at $4.37M in Q1 2015.
- 657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.
Based on Roffman Miller Associates's 13F filing for Q3 2023, filed 9 Nov 2023.